ArticleBiomarker research2025
Tumor-specific MHC-II guides anthracycline exemption and immunotherapy benefit in breast cancer.
Zehao Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleBiomarker research2025
Zehao Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.